Načítá se...
Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B
OBJECTIVE: To delineate the rate and duration of transient hepatitis B surface antigenemia following Heplisav-B vaccination. PATIENTS AND METHODS: We retrospectively reviewed the medical records of all adult patients who received Heplisav-B vaccination at our institution from January 1, 2019, throug...
Uloženo v:
| Vydáno v: | Mayo Clin Proc Innov Qual Outcomes |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8240146/ https://ncbi.nlm.nih.gov/pubmed/34195546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocpiqo.2020.10.010 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|